An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma

Figure 6

The decision analysis curve in the (a) training, (b) internal validation, and (c) external validation cohorts. Model 1: the present model; model 2: up-to-seven; model 3: four-and-seven; model 4: six-and-twelve; model 5: BCLC-B substaging system; model 6: new BCLC-B substaging system; model 7: HAP; model 8: mHAP II; model 9: ALBI-TAE model.

(a)

(b)

(c)